NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Vaxfab Enterprises Surges 19% to Reach 52-Week High

Vaxfab Enterprises, a small-cap stock, witnessed a significant surge of 19% on Monday, 1 June, to touch a 52-week high of ₹60. The Ahmedabad-based company reported a sharp improvement in its financial performance for the fiscal year (FY) 2026.

According to the company's financial reports, Vaxfab Enterprises posted total income of ₹99.60 crore for FY26, a notable increase of 67.7% year-on-year from ₹59.38 crore in the previous fiscal. The net profit surged an impressive 523% to ₹3.64 crore, compared with ₹58.42 lakh in FY25. The company's Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) climbed more than seven-fold to ₹5.21 crore from ₹73.77 lakh a year ago.

For the March quarter, Vaxfab Enterprises reported total income of ₹18.37 crore. The quarterly net profit jumped 329% year-on-year to ₹3.01 crore from ₹70.36 lakh, while EBITDA stood at ₹6.98 crore.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Comparison of FY26 Financial Performance

Financial MetricFY26FY25
Total Income₹99.60 crore₹59.38 crore
Net Profit₹3.64 crore₹58.42 lakh
EBITDA₹5.21 crore₹73.77 lakh

Commenting on the performance, Ravindra Joshi, Managing Director of Vaxfab Enterprises, highlighted the company's strong growth in revenue, profitability, and operational efficiency during FY26. Joshi also mentioned that the company has laid the groundwork for its next phase of expansion by diversifying into textile products and clothing, alongside its core agriculture-related business. This diversification strategy is expected to broaden the company's market presence, create additional revenue streams, and support long-term value creation for shareholders.

The Indian stock market witnessed sharp selling pressure on Monday, 1 June, after an optimistic start to the session, as investors resorted to profit-booking amid persistent concerns over elevated crude oil prices and the absence of any concrete breakthrough in the Middle East conflict. Benchmark indices erased early gains and ended the day firmly in the red. The BSE Sensex declined 508.40 points, or 0.68%, to close at 74,267.34, while the NSE Nifty 50 fell 165.15 points, or 0.70%, to settle at 23,382.60.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Vaxfab Enterprises' share price has delivered strong returns across multiple timeframes, reflecting sustained investor interest in the small-cap stock. Over the past one week, the stock has gained 5.32%, while its two-week and one-month returns stand at 8.38% and 9.84%, respectively. The momentum has remained robust over the medium term, with the stock rising 22.79% in three months, 43.89% year to date, and 49.73% over the last six months. The rally comes amid improved financial performance, with the company reporting sharp growth in revenue, profit, and EBITDA for FY26, supported by business expansion and diversification into textile products and clothing.

Investor Takeaway

Investors should consider Vaxfab Enterprises as a potential multibagger stock due to its strong financial performance and growth prospects.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.